Also, it may be more relevant for extreme paracetamol toxicity in patients (3)
Eli Lillys orforglipron continues to advance but has not yet reached benchmark weight loss efficacy
At Wellstar, we truly believe each and every person deserves to live their healthiest life, regardless of their circumstances
As GLP-1 receptor agonists, these peptide drugs mimic the incretin hormone GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and reducing appetite [9]
Contact us to explore how we can support your commercial and medical teams in navigating this evolving landscape: #LifeSciences #PharmaStrategy #HealthcareTrends #MarketAccess #GLP1 #Obesity #Pharma #PharmaMarket #Treatment #Healthcare #Health #Economy GLP-1 drugs transform obesity care, but challenges remain Obesity isnt just about weight
If gastroparesis is diagnosed, treatment may include the following: Eating smaller, low-fat meals that are easier to digest Slowing the rate at which your GLP-1 dose is increased Taking medications to help manage digestion and reduce nausea Pausing or stopping the GLP-1 medication entirely Everyone responds differently to treatment, so it's important to work closely with your care team to find the right plan for you
